{"product_id":"abalam-tablets-600mg-300mg","title":"Abalam Tablets 600mg\/300mg","description":"\u003ch2 data-path-to-node=\"5\"\u003eIntroduction to Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"6\"\u003eAbalam Tablets 600mg\/300mg is a fixed-dose combination medication containing the active substances Abacavir (600mg) and Lamivudine (300mg). It belongs to the class of antiretroviral drugs known as Nucleoside Reverse Transcriptase Inhibitors (NRTIs). This medication is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in adults, adolescents, and pediatric patients weighing at least 25 kg.\u003c\/p\u003e\n\u003cp data-path-to-node=\"7\"\u003eBoth Abacavir and Lamivudine work by selectively inhibiting the HIV reverse transcriptase enzyme, an essential component the virus requires to replicate its genetic material. By blocking this enzyme, Abalam Tablets stop the virus from multiplying, thereby reducing the viral load (amount of virus in the blood) and increasing the CD4+ cell count (immune cells). This actions strengthens the immune system and significantly lowers the risk of developing HIV-associated secondary infections or complications.\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003eAbalam Tablets 600mg\/300mg must be used under the strict supervision of an infectious disease specialist or HIV healthcare professional. It is vital to understand that while this medication effectively controls the replication of HIV, it is not a cure for HIV infection.\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003e\u003cb data-path-to-node=\"9\" data-index-in-node=\"0\"\u003eCritical Warning:\u003c\/b\u003e A percentage of patients carrying a specific genetic marker known as the HLA-B\u003ci data-path-to-node=\"9\" data-index-in-node=\"96\"\u003e5701 allele can develop a severe, potentially life-threatening hypersensitivity (allergic) reaction to Abacavir. Patients must be screened for the HLA-B\u003c\/i\u003e5701 allele by a blood test before initiating treatment with Abalam Tablets. Do not use this medication if you test positive for this genetic marker or if you have a known history of severe hypersensitivity to Abacavir or Lamivudine.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10\"\u003eBefore starting treatment, inform your doctor if you have a history of liver disease (such as Hepatitis B or C), kidney impairment, heart disease, high blood pressure, diabetes, or risk factors for metabolic conditions like lactic acidosis. Seek immediate emergency medical care if you develop symptoms of an allergic reaction (fever, rash, fatigue, nausea, vomiting, breathing difficulties) or signs of lactic acidosis (deep, rapid breathing, muscle weakness, severe stomach pain).\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"11\"\u003eUses of Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"12\"\u003eUses of Abalam Tablets 600mg\/300mg:\u003c\/p\u003e\n\u003cul data-path-to-node=\"13\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"13,0,0\"\u003eTreatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in combination with other antiretroviral medications\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"13,1,0\"\u003eReduction of viral load to maintain long-term viral suppression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"13,2,0\"\u003ePreservation and improvement of immune system function (increasing CD4+ T-cell counts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"14\"\u003eTherapeutic Effects of Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"15\"\u003eAbalam Tablets 600mg\/300mg work cooperatively to halt viral proliferation. Both components are intracellularly phosphorylated into active metabolites that directly compete with natural viral building blocks. This competitive inhibition terminates the synthesis of viral DNA chains during reverse transcription. Consequently, the medication effectively halts the expansion of HIV-1 within the host immune system, minimizing structural immune degradation and allowing the body's natural defense mechanisms to rebuild.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"16\"\u003eInteraction of Abalam Tablets 600mg\/300mg with other drugs\u003c\/h2\u003e\n\u003cp data-path-to-node=\"17\"\u003eIt is important to inform your healthcare professional about all the medications you are taking, including prescription drugs, over-the-counter medications, nutritional supplements, and herbal products. Some medications may interact with Abalam Tablets 600mg\/300mg, potentially affecting their effectiveness or causing serious side effects. Notable interactions include:\u003c\/p\u003e\n\u003cul data-path-to-node=\"18\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"18,0,0\"\u003e\u003cb data-path-to-node=\"18,0,0\" data-index-in-node=\"0\"\u003eEmtricitabine:\u003c\/b\u003e Should not be co-administered with Lamivudine as they are highly similar and compete with each other, rendering the combination ineffective.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"18,1,0\"\u003e\u003cb data-path-to-node=\"18,1,0\" data-index-in-node=\"0\"\u003eMethadone:\u003c\/b\u003e Abacavir may increase the clearance of methadone, occasionally requiring a re-evaluation of methadone dosages.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"18,2,0\"\u003e\u003cb data-path-to-node=\"18,2,0\" data-index-in-node=\"0\"\u003eRibavirin \/ Interferon alpha:\u003c\/b\u003e Used for treating Hepatitis C; combined use with Lamivudine may increase the risk of severe liver toxicity or lactic acidosis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"18,3,0\"\u003e\u003cb data-path-to-node=\"18,3,0\" data-index-in-node=\"0\"\u003eTrimethoprim\/Sulfamethoxazole (Co-trimoxazole):\u003c\/b\u003e Can increase the concentration of Lamivudine in the blood; monitoring is advised if high doses are used.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"19\"\u003eMore Information about Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cul data-path-to-node=\"20\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"20,0,0\"\u003eKeep out of reach of children and pets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"20,1,0\"\u003eStore in a dry place at a temperature not exceeding 30°C.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"20,2,0\"\u003eKeep the tablets stored inside their original moisture-resistant container or bottle, tightly capped.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"21\"\u003eHow to consume Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"22\"\u003eAbalam Tablets 600mg\/300mg are oral medications intended to be swallowed whole with a glass of water. They should not be crushed or split if used at full dosage. They can be taken with or without food. To achieve optimal viral suppression, it is absolutely essential to take this medication exactly as prescribed, at the same time every single day. Adherence is critical; skipping doses can cause the virus to develop genetic resistance to the medication.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"23\"\u003eSafety Advice for Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003ch3 data-path-to-node=\"24\"\u003eBreast Feeding\u003c\/h3\u003e\n\u003cp data-path-to-node=\"25\"\u003e\u003cb data-path-to-node=\"25\" data-index-in-node=\"0\"\u003eUnsafe\u003c\/b\u003e HIV-infected mothers should not breastfeed to avoid transmitting the virus to the infant. Additionally, Abacavir and Lamivudine pass into breast milk and can cause adverse side effects in a nursing child.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"26\"\u003eAlcohol\u003c\/h3\u003e\n\u003cp data-path-to-node=\"27\"\u003e\u003cb data-path-to-node=\"27\" data-index-in-node=\"0\"\u003eCaution\u003c\/b\u003e Avoid or strictly limit alcohol consumption while taking Abalam Tablets. Alcohol increases the workload on the liver and elevates the risk of developing liver toxicity, pancreatitis, or metabolic imbalances.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"28\"\u003eLiver\u003c\/h3\u003e\n\u003cp data-path-to-node=\"29\"\u003e\u003cb data-path-to-node=\"29\" data-index-in-node=\"0\"\u003eCaution\u003c\/b\u003e Abalam Tablets are processed by the liver. Patients with pre-existing mild liver impairment require close monitoring, while the drug is typically not recommended for moderate-to-severe hepatic impairment. Regular liver function tests (LFTs) are mandatory.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"30\"\u003eLungs\u003c\/h3\u003e\n\u003cp data-path-to-node=\"31\"\u003e\u003cb data-path-to-node=\"31\" data-index-in-node=\"0\"\u003eConsult Your Doctor\u003c\/b\u003e Respiratory symptoms like shortness of breath or a cough can sometimes be a sign of a severe Abacavir hypersensitivity reaction rather than a chest infection. Consult your doctor immediately if any respiratory discomfort develops.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"32\"\u003eDriving\u003c\/h3\u003e\n\u003cp data-path-to-node=\"33\"\u003e\u003cb data-path-to-node=\"33\" data-index-in-node=\"0\"\u003eConsult Your Doctor\u003c\/b\u003e Abalam Tablets generally do not impair your ability to drive or operate machinery. However, if you experience dizziness, headache, or profound fatigue, avoid driving until you feel fully alert.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"34\"\u003ePregnancy\u003c\/h3\u003e\n\u003cp data-path-to-node=\"35\"\u003e\u003cb data-path-to-node=\"35\" data-index-in-node=\"0\"\u003eConsult Your Doctor\u003c\/b\u003e Abalam Tablets should be used during pregnancy only if the potential therapeutic benefits heavily outweigh the potential risks to the fetus. Discuss your options thoroughly with your specialist.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"36\"\u003eSide Effects of Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"37\"\u003eSide effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.\u003c\/p\u003e\n\u003cp data-path-to-node=\"38\"\u003eCommon side effects of Abalam Tablets 600mg\/300mg are:\u003c\/p\u003e\n\u003cul data-path-to-node=\"39\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"39,0,0\"\u003eNausea, vomiting, or diarrhea\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"39,1,0\"\u003eHeadaches or dizziness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"39,2,0\"\u003eFatigue, lethargy, or generalized weakness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"39,3,0\"\u003eTrouble sleeping (insomnia) or unusual dreams\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"39,4,0\"\u003eMild skin rashes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-path-to-node=\"40\"\u003eSerious side effects of Abalam Tablets 600mg\/300mg are:\u003c\/p\u003e\n\u003cul data-path-to-node=\"41\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"41,0,0\"\u003e\u003cb data-path-to-node=\"41,0,0\" data-index-in-node=\"0\"\u003eAbacavir Hypersensitivity Reaction:\u003c\/b\u003e (Fever, severe rash, extreme fatigue, body aches, sore throat, cough, abdominal pain).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"41,1,0\"\u003e\u003cb data-path-to-node=\"41,1,0\" data-index-in-node=\"0\"\u003eLactic Acidosis:\u003c\/b\u003e (Deep, rapid breathing, unexpected muscle pain, cold extremities, severe nausea, fast heart rate).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"41,2,0\"\u003e\u003cb data-path-to-node=\"41,2,0\" data-index-in-node=\"0\"\u003eHepatomegaly with Steatosis (Severe Liver Issues):\u003c\/b\u003e (Yellowing eyes\/skin, dark urine, severe pain in the upper right side of the abdomen).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"41,3,0\"\u003e\u003cb data-path-to-node=\"41,3,0\" data-index-in-node=\"0\"\u003eImmune Reconstitution Syndrome:\u003c\/b\u003e (An overactive inflammatory response against old or hidden infections as the immune system recovers).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"42\"\u003eWord of Advice\u003c\/h2\u003e\n\u003cp data-path-to-node=\"43\"\u003eAlways carry your Abacavir Warning Card (usually provided with the packaging) with you at all times. It lists the crucial symptoms of an allergic reaction. If you stop taking Abalam Tablets due to a suspected allergic reaction, \u003cb data-path-to-node=\"43\" data-index-in-node=\"228\"\u003enever restart taking it\u003c\/b\u003e, as doing so can trigger an immediate, fatal drop in blood pressure. Ensure you keep all appointments for laboratory tests, including liver function, kidney function, and viral load measurements. Do not stop taking this medication unless explicitly instructed by your HIV care specialist.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"44\"\u003eFAQs about Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cp data-path-to-node=\"45\"\u003e\u003cb data-path-to-node=\"45\" data-index-in-node=\"0\"\u003eQ1. What is the HLA-B*5701 genetic test and why is it mandatory before taking Abalam?\u003c\/b\u003e The HLA-B*5701 test is a genetic screening blood test. It determines if you are at a high risk of developing a severe, life-threatening allergic reaction to Abacavir. If the test is positive, your doctor will select an alternative medication instead of Abalam.\u003c\/p\u003e\n\u003cp data-path-to-node=\"46\"\u003e\u003cb data-path-to-node=\"46\" data-index-in-node=\"0\"\u003eQ2. What should I do if I suspect I am having an allergic reaction to Abalam Tablets?\u003c\/b\u003e If you develop a fever, rash, or respiratory issues (like a cough or shortness of breath) along with nausea or fatigue, stop taking the medication and contact your doctor or go to the nearest emergency room immediately.\u003c\/p\u003e\n\u003cp data-path-to-node=\"47\"\u003e\u003cb data-path-to-node=\"47\" data-index-in-node=\"0\"\u003eQ3. Can Abalam Tablets prevent me from passing HIV to others?\u003c\/b\u003e Taking Abalam Tablets and achieving an \"undetectable\" viral load effectively reduces the risk of transmitting HIV through sexual contact to zero. However, it is still recommended to practice safe sex and use condoms to prevent other sexually transmitted infections (STIs).\u003c\/p\u003e\n\u003cp data-path-to-node=\"48\"\u003e\u003cb data-path-to-node=\"48\" data-index-in-node=\"0\"\u003eQ4. What happens if I have chronic Hepatitis B and stop taking Abalam Tablets?\u003c\/b\u003e Lamivudine (one of the components in Abalam) is also active against the Hepatitis B virus (HBV). If you have both HIV and HBV and suddenly stop taking this medicine, your Hepatitis B infection can suddenly flare up and cause severe liver damage. Never stop treatment without your doctor's explicit guidance.\u003c\/p\u003e\n\u003cp data-path-to-node=\"49\"\u003e\u003cb data-path-to-node=\"49\" data-index-in-node=\"0\"\u003eQ5. Can I take standard antacids or vitamin supplements along with Abalam Tablets?\u003c\/b\u003e Most standard antacids do not significantly interfere with Abalam. However, you should always provide a comprehensive list of all supplements and over-the-counter drugs to your doctor to ensure no specific interactions occur.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"50\"\u003eFact Box of Abalam Tablets 600mg\/300mg\u003c\/h2\u003e\n\u003cul data-path-to-node=\"51\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"51,0,0\"\u003e\u003cb data-path-to-node=\"51,0,0\" data-index-in-node=\"0\"\u003eMolecule name:\u003c\/b\u003e Abacavir (600mg) + Lamivudine (300mg)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"51,1,0\"\u003e\u003cb data-path-to-node=\"51,1,0\" data-index-in-node=\"0\"\u003eTherapeutic class:\u003c\/b\u003e Antiretrovirals\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"51,2,0\"\u003e\u003cb data-path-to-node=\"51,2,0\" data-index-in-node=\"0\"\u003ePharmacological class:\u003c\/b\u003e Nucleoside Reverse Transcriptase Inhibitors (NRTIs)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"51,3,0\"\u003e\u003cb data-path-to-node=\"51,3,0\" data-index-in-node=\"0\"\u003eIndications:\u003c\/b\u003e 1. Management and treatment of HIV-1 infection in adults and children weighing 25 kg or more.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"52\"\u003eReferences\u003c\/h2\u003e\n\u003col start=\"1\" data-path-to-node=\"53\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"53,0,0\"\u003eShuter J, et al. Fixed-dose combination of abacavir and lamivudine for the treatment of HIV-1 infection. \u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003ca rel=\"noopener\" href=\"https:\/\/www.google.com\/search?q=https:\/\/pubmed.ncbi.nlm.nih.gov\/16542121\/\" class=\"ng-star-inserted\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwjixcTjm8KUAxUAAAAAHQAAAAAQqAI\" target=\"_blank\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/16542121\/\u003c\/a\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"53,1,0\"\u003eNational Institutes of Health. Clinical Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. [Updated 2025\/2026]. Available from: \u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003ca rel=\"noopener\" href=\"https:\/\/clinicalinfo.hiv.gov\/\" class=\"ng-star-inserted\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwjixcTjm8KUAxUAAAAAHQAAAAAQqQI\" target=\"_blank\"\u003ehttps:\/\/clinicalinfo.hiv.gov\/\u003c\/a\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"53,2,0\"\u003eWorld Health Organization (WHO). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. \u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003ca rel=\"noopener\" href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240031593\" class=\"ng-star-inserted\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwjixcTjm8KUAxUAAAAAHQAAAAAQqgI\" target=\"_blank\"\u003ehttps:\/\/www.who.int\/publications\/i\/item\/9789240031593\u003c\/a\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"53,3,0\"\u003eFood and Drug Administration (FDA). Epzicom (Abacavir and Lamivudine) Prescribing Information and Boxed Warning Data. \u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003ca rel=\"noopener\" href=\"https:\/\/www.google.com\/search?q=https:\/\/www.accessdata.fda.gov\/\" class=\"ng-star-inserted\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwjixcTjm8KUAxUAAAAAHQAAAAAQqwI\" target=\"_blank\"\u003ehttps:\/\/www.accessdata.fda.gov\/\u003c\/a\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c!----\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2 data-path-to-node=\"54\"\u003eDisclaimer\u003c\/h2\u003e\n\u003cp data-path-to-node=\"55\" id=\"p-rc_8d9f2a09f32ad901-24\"\u003eMedipoint India’s primary i\u003cspan class=\"citation-13 citation-end-13\"\u003entention is to ensure that its consumers get accurate, trustworthy, and expert-reviewed information. The contents of this website are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your do\u003csup class=\"superscript\" data-turn-source-index=\"1\"\u003e\u003c!----\u003e\u003c\/sup\u003e\u003c\/span\u003ector and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Medipoint India. Our mission is to support, not replace, the doctor-patient relationship.\u003c\/p\u003e","brand":"Medipoint India","offers":[{"title":"Default Title","offer_id":47891016155354,"sku":null,"price":3048.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/2332\/5658\/files\/abalam-tablets-600mg-300mg-1000x1000.webp?v=1779086834","url":"https:\/\/www.medipointindia.com\/products\/abalam-tablets-600mg-300mg","provider":"Medipoint India","version":"1.0","type":"link"}